Chison Medical Technologies 관리

관리 기준 확인 2/4

Chison Medical Technologies CEO는 Ruoli Mo, Aug2002 에 임명되었습니다 의 임기는 22.25 년입니다. 는 CN¥ 700.40M 가치에 해당하는 회사 주식의 23.6% 직접 소유합니다. 700.40M. 경영진과 이사회의 평균 재임 기간은 각각 14.7 년과 1.3 년입니다.

주요 정보

Ruoli Mo

최고 경영자

CN¥780.4k

총 보상

CEO 급여 비율	n/a
CEO 임기	22.3yrs
CEO 소유권	23.6%
경영진 평균 재임 기간	14.7yrs
이사회 평균 재임 기간	1.3yrs

최근 관리 업데이트

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Nov 06

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

Oct 08

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Sep 27

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

Apr 25

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Mar 04

CEO

Ruoli Mo (50 yo)

22.3yrs

테뉴어

CN¥780,400

보상

Ms. Ruoli Mo is General Manager of Chison Medical Technologies Co., Ltd. since August 2002 and also serves as its Director since August 2017 and also serves as its Chairman since August 2023.

리더십 팀

이름	위치	테뉴어	보상	소유권
Ruoli Mo	GM & Chairman	22.3yrs	CN¥780.40k	23.6% CN¥ 700.4m
Feng Zhou	Deputy GM	7.3yrs	CN¥835.00k	데이터 없음
Wang Hong	Chief Technology Officer	12.1yrs	CN¥1.49m	데이터 없음
Zhang Yong	Director of R & D Center High-End Color Doppler Ultrasound	17.3yrs	CN¥1.04m	데이터 없음

14.7yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 관리: 688358 의 관리팀은 노련하고 경험 (평균 재직 기간 14.7 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ruoli Mo	GM & Chairman	7.3yrs	CN¥780.40k	23.6% CN¥ 700.4m
Feng Zhou	Deputy GM	7.3yrs	CN¥835.00k	데이터 없음
Shouxi Li	Independent Director	1.3yrs	CN¥42.20k	데이터 없음
Ancheng Song	Independent Director	1.3yrs	CN¥42.20k	데이터 없음
Yaoxin Hu	Chairman of the Board of Supervisors	1.3yrs	CN¥77.90k	데이터 없음
Dongliang Gong	Supervisor & Software Department Manager	1.3yrs	CN¥237.10k	데이터 없음

1.3yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 이사회: 688358 의 이사회는 경험(평균 재직 기간 1.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Chison Medical Technologies 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Chison Medical Technologies Co., Ltd., Annual General Meeting, May 10, 2024

Recent updates

Chison Medical Technologies' (SHSE:688358) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Third quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.26 in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

The Market Lifts Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares 39% But It Can Do More

New minor risk - Share price stability

Chison Medical Technologies Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Capital Allocation Trends At Chison Medical Technologies (SHSE:688358) Aren't Ideal

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: CN¥0.32 (vs CN¥0.53 in 2Q 2023)

Chison Medical Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.47 in 1Q 2023)

Chison Medical Technologies Co., Ltd., Annual General Meeting, May 10, 2024

Now 21% undervalued after recent price drop

Chison Medical Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 19, 2024

Investor sentiment improves as stock rises 18%

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Now 23% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.44 in 3Q 2022)

Chison Medical Technologies Co., Ltd. (SHSE:688358) commences an Equity Buyback for CNY 20 million worth of its shares, under the authorization approved on September 12, 2023.

Second quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.46 in 2Q 2022)

Chison Medical Technologies Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 31%

First quarter 2023 earnings released: EPS: CN¥0.47 (vs CN¥0.22 in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.22 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.28 in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.27 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.32 (vs CN¥1.70 in FY 2019)

New 90-day low: CN¥49.00

New 90-day low: CN¥54.52

New 90-day low - CN¥61.94

New 90-day low - CN¥67.90

Chison Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령